Laura Dawson, MD
Closed to Accrual
To determine if SBRT improves overall survival in HCC patients treated with Sorafenib
Unsuitable for resection or transplant or radiofrequency ablation (RFA); Unsuitable for TACE or refractory to TACE; Barcelona Clinic Liver Cancer Stage (BCLC) Intermediate (B) or Advanced (C)
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.